Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OXCARBAZEPINE for Multiple sclerosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 10 adverse event reports in the FDA FAERS database where OXCARBAZEPINE was used for Multiple sclerosis.

Most Reported Side Effects for OXCARBAZEPINE

Side Effect Reports % Deaths Hosp.
Seizure 1,525 14.1% 57 367
Drug ineffective 1,498 13.9% 25 365
Off label use 751 7.0% 45 291
Hyponatraemia 708 6.6% 10 367
Somnolence 634 5.9% 6 174
Dizziness 558 5.2% 7 199
Fatigue 551 5.1% 6 113
Epilepsy 509 4.7% 15 146
Headache 505 4.7% 3 145
Asthenia 429 4.0% 3 131
Rash 408 3.8% 26 167
Balance disorder 402 3.7% 1 150
Toxicity to various agents 361 3.3% 160 260
Anxiety 360 3.3% 8 63
Fall 355 3.3% 7 224

Other Indications for OXCARBAZEPINE

Product used for unknown indication (3,322) Epilepsy (2,088) Seizure (1,160) Partial seizures (474) Trigeminal neuralgia (360) Bipolar disorder (228) Generalised tonic-clonic seizure (167) Status epilepticus (140) Affective disorder (112) Neuralgia (84)

Other Drugs Used for Multiple sclerosis

DIMETHYL (78,567) NATALIZUMAB (56,733) INTERFERON BETA-1A (56,475) FINGOLIMOD (43,123) TERIFLUNOMIDE (29,963) DALFAMPRIDINE (28,787) GLATIRAMER (27,144) OCRELIZUMAB (15,501) OFATUMUMAB (11,816) PEGINTERFERON BETA-1A (11,105)

Related Pages

OXCARBAZEPINE Full Profile All Multiple sclerosis Drugs OXCARBAZEPINE Demographics OXCARBAZEPINE Timeline